CLOV vs DTIL · rev $1.37B vs rev $68.7M
Clover Health Investments Corp (CLOV) versus Precision BioSciences Inc (DTIL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DTIL revenue for 2024-12-31 was $68.7M. Net income was $7.2M. Revenue was up 41.0% from 2023-12-31 to 2024-12-31. DTIL currently screens at market cap $48.1M.
CLOV currently screens at market cap $1.55B. DTIL currently screens at market cap $48.1M.
Not investment advice. Open the CLOV and DTIL stock pages for the full models.
Not investment advice.